Matinas BioPharma Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTNB research report →
Companywww.matinasbiopharma.com
Matinas BioPharma Holdings, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology.
- CEO
- Jerome D. Jabbour
- IPO
- 2014
- Employees
- 3
- HQ
- Bedminster, NJ, US
Price Chart
Valuation
- Market Cap
- $3.54M
- P/E
- -0.36
- P/S
- 0.00
- P/B
- 1.35
- EV/EBITDA
- -0.33
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -204.27%
- ROIC
- -155.55%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-10,345,000 · 57.34%
- EPS
- $-2.00 · 59.84%
- Op Income
- $-6,960,000
- FCF YoY
- 55.86%
Performance & Tape
- 52W High
- $3.09
- 52W Low
- $0.48
- 50D MA
- $0.58
- 200D MA
- $1.02
- Beta
- 1.62
- Avg Volume
- 130.00K
Get TickerSpark's AI analysis on MTNB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 30, 25 | NEUGEBOREN EDWARD | other | 11,600 |
| Apr 30, 25 | Smith Robin L | other | 11,600 |
| Apr 30, 25 | D An Evelyn | other | 11,600 |
| Apr 30, 25 | Jabbour Jerome D | other | 70,100 |
| Apr 30, 25 | Murphy Keith | other | 11,600 |
| Feb 13, 25 | STERN ADAM K | other | 0 |
| Feb 13, 25 | STERN ADAM K | other | 2,399,318 |
| Feb 13, 25 | STERN ADAM K | other | 4,798,636 |
| Apr 8, 25 | Sanitam Partners LLC | buy | 2,399,318 |
| Apr 8, 25 | Sanitam Partners LLC | buy | 703 |
Our MTNB Coverage
We haven't published any research on MTNB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MTNB Report →